Drug Experts Concerned About Increased Chinese-Drug Exports To U.S., Europe (China)
This article was originally published in PharmAsia News
Pharmaceutical companies in China have doubled their exports to the United States in the past five years, and some industry experts are raising national-security concerns. They note that the ingredients for anthrax vaccines no longer exist in the West, leaving the area to rely on China and India to produce the drugs after Western supplies are exhausted. There also are concerns about the safety of Chinese factories and the long-term stability of trade between China, and U.S. European industry experts voice similar national-security concerns. (Click here for more
You may also be interested in...
Pain relief product sales grew 27% and upper respiratory sales 35% for the week ended 7 March as consumers respond to COVID-19, according to Nielsen data noted in a Jefferies report on consumer health purchasing trends. Private label market share is up slightly, while OTC purchases continue primarily in conventional stores.
Managing partner Corey Goodman said venBio didn’t have trouble closing its fund, because the venture capital firm prepared its investors for an economic downturn months ago.
The US FDA has proposed moving two categories of hepatitis C diagnostics to class II from class III because they pose relatively low risk.